NCT01692756View on ClinicalTrials.gov

Early Treatment for Acute ACL Tear

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 5, 2017

Study Completion Date

February 5, 2017

Conditions
Anterior Cruciate Ligament (ACL) Tears
Interventions
DRUG

Kenalog or placebo

DRUG

Kenalog then Placebo

DRUG

Kenalog

DRUG

Placebo

Trial Locations (1)

40517

UK HeathCare Sports Medicine, Lexington

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

lead

Cale Jacobs

OTHER

NCT01692756 - Early Treatment for Acute ACL Tear | Biotech Hunter | Biotech Hunter